SRSF3 and cancer: The preferential SRSF3‐mediated processing of the paralogs miR‐17 and miR‐20a led to enhanced cell cycle progression and proliferation in both mouse pluripotent and human cancer cells through the regulation of the cell cycle inhibitor CDKN1A/p21.